Position in LQDA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,029,767
-$12,827,562 QoQ
Shares Held
80,280
-82.5% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 99.62630792227205.ToString("F0")%
Shared 0.ToString("F0")%
None 0.37369207772795215.ToString("F0")%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PRUDENTIAL FINANCIAL INC holds $156,211,352 across 33 Drug Manufacturers - Specialty & Generic names. LQDA ranks #15 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
225,051 | $29,648,218 | |
| 2 | ZTS |
Zoetis Inc.
|
202,071 | $23,886,812 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
34,281 | $20,327,947 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
449,847 | $10,764,838 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
286,100 | $8,720,328 | |
| 6 | VTRS |
Viatris Inc
|
597,766 | $8,075,817 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
511,957 | $6,363,625 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
207,156 | $6,239,538 |
All Filings in LQDA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,029,767 | 80,280 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $15,857,329 | 459,766 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $535,640 | 23,555 | Shares | Defined | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||